VR Logo

Lupin Ltd.


Healthcare | Drugs & Pharma

we think vacations are for wimps

39 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: Manufacture of pharmaceuticals, medicinal chemical and botanical products

Incorporated: 1983

Chairman: Manju D Gupta

Managing Director: Nilesh Gupta

Group: Lupin

Listing: NSE: LUPIN, BSE: 500257

Headquarters: Mumbai, Maharashtra

Website: www.lupinworld.com

Key Facts

Market cap: R 40,435.08 Cr

Revenue (TTM): R 14,977.87 Cr

Earnings (TTM): R -129.84 Cr

Cash: R 4,792.55 Cr

Total Debt: R 6,305.32 Cr

Promoters' ownership: 46.91%

Liquidity: High

52 Week range: R 504.75 - 1,122.30

Face value: R2.00

Shares outstanding: 45,34,09,685

10 Years Aggregate:

  • CFO: 15,963.08 Cr
  • EBITDA: 27,984.10 Cr
  • Net Profit: 12,835.09 Cr

Stock Performance

Time Period Lupin S&P BSE Sensex S&P BSE Healthcare
YTD16.597.0251.30
1 month-6.7511.455.51
3 months-9.2814.2910.50
1 Year12.528.2349.36
3 Years2.3710.0413.27
5 Years-13.2311.054.51
10 Years6.188.5011.93
As on 27-Nov-2020
Year Lupin S&P BSE Sensex S&P BSE Healthcare
2019-9.2714.38-3.55
2018-4.595.87-5.89
2017-40.4827.910.49
2016-19.421.95-12.88
201528.55-5.0315.06
201455.8029.8947.43
201347.748.9822.55